Mental Health

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/41

flashcard set

Earn XP

Description and Tags

Vocabulary practice flashcards covering pathophysiology, assessment, diagnostic criteria, psychopharmacology, and clinical management across adult mental health conditions from the GNUR 650 lectures.

42 Terms

1
New cards

Adverse Childhood Experiences (ACEs)

Potentially traumatic events occurring during childhood (prior to age 1010 on standard screening tools) linked to risky health behaviors, chronic disease, lower socioeconomic potential, and early death in adulthood.

2
New cards
<p>The Pair of ACEs Framework</p>

The Pair of ACEs Framework

A visual framework developed by Ellis (20202020) illustrating that individual Adverse Childhood Experiences (the tree branches, e.g., abuse, neglect, maternal depression) are rooted in and sustained by Adverse Community Environments (the tree roots, e.g., poverty, discrimination, community disruption, poor housing, and violence).

3
New cards

Recovery-Oriented Language

Non-stigmatizing, person-centered phrasing used in clinical documentation and patient care, such as substituting 'declined' for 'refused', 'chose not to' for 'resisted', 'seeking alternatives' for 'manipulative', 'not in agreement' for 'noncompliant', and 'person diagnosed with alcohol use disorder' for 'alcoholic'.

4
New cards

Monoamine Hypothesis of Depression

A pathophysiological theory positing that depressive symptoms stem from a functional depletion of the monoamine neurotransmitters serotonin, norepinephrine, and dopamine, which can be restored by pharmacologic agents blocking their reuptake transporters.

5
New cards

Mesolimbic Dopamine Pathway

The principal neurobiological reward and reinforcement circuit originating in the ventral tegmental area and projecting to the ventral striatum (nucleus accumbens); all substances capable of inducing dependence trigger explosive dopamine release within this circuit.

6
New cards

Major Depressive Disorder (MDD)

A mood disorder requiring a minimum of 2 weeks2\text{ weeks} of persistent symptoms, featuring at least 55 out of 99 specific diagnostic criteria (with at least one being depressed mood or anhedonia) present on most days, resulting in significant clinical distress or functional impairment.

7
New cards

depression presentation

__ presentation

  • Sadness/tearfulness

  • Anhedonia

  • Change in weight or appetite

  • Insomnia or hypersomnia

  • Psychomotor agitation

  • Fatigue/energy loss

  • Feelings of worthlessness or guilt

  • Diminished concentration or indecisiveness

  • Suicidal ideation


8
New cards

depression treatment

__ treatmnet

  • 1st line pharm = SSRIs

  • CBT

  • Social support

  • ECT

  • Light therapy


9
New cards

ssris

fluoxetine, sertraline, escitalopram, citalopram

ADRs:

  • insomnia/agitation

  • QTc prolongation

  • GI distress

  • Wt. gain

  • Sexual dysfunction

  • Drowsiness

  • Anticholinergic effects


10
New cards

serotonin syndrome

A potentially life-threatening condition resulting from excessive serotonergic activity in the nervous system, often caused by the use of certain medications or drug interactions.

Sx:

  • AMS

  • myoclonus

  • hyperreflexia

  • hallucinations

  • seizures

  • tachycardia/HTN

  • GI sx


11
New cards

1-2d

follow up interval when starting a acutely depressed pt on meds

12
New cards

red flags

  • Hallucinations

  • Delusions

  • Suicidal or homicidal thoughts

  • Extreme self-care deficit

  • Asverse effect after medications prescribed


13
New cards

sadpersonas

A mnemonic used to assess suicide risk that includes factors

  • Sex

  • Age

  • Depression

  • Previous attempt

  • Ethanol abuse

  • Rational thinking loss

  • Social support loss

  • Organized plan

  • No spouse

  • Availability of lethal means

  • Sickness


14
New cards

snris

duloxetine, velafaxine, desvenlafaxine

15
New cards

TCA

Amitriptyline, nortriptyline

16
New cards

maois

isocarboxazid, phenelzine, tranylcypromine, and selegiline

17
New cards

50 (%)

What percentage of symptom reduction is the goal with pharmacology for depression?

18
New cards

Dysthymia (Persistent Depressive Disorder)

A chronic depressive state marked by depressed mood most of the day, for more days than not, lasting at least 2 years2\text{ years} in adults (1 year1\text{ year} in children and adolescents) accompanied by at least 22 of 66 core symptoms, without being asymptomatic for more than 2 months2\text{ months} at a time.

19
New cards

Generalized Anxiety Disorder (GAD)

Persistent, excessive, and uncontrollable worry occuring on more days than not for at least 6mo accompanied by sx like muscle tension, fatigue, restlessness, poor concentration, sleep impairment, and irritability.

20
New cards

anxiety differentials

__ differentials

  • Cancer

  • MV prolapse

  • Arrhythmia

  • CHF

  • Ischemic heard dx

  • Asthma/COPD

  • OSA

  • PE

  • Hypercapnia or hypoxia

  • Meniere’s dx

  • CVA/TIA

  • MS

  • Encephalopathy

  • SDH

  • Thyroid disorder

  • Cushing’s/Addison’s

  • Altered glucose levels

  • Folate/B12/iron deficiency

  • Rx (amniophylline, dig, lidocaine, NSAIDs, steroids)

  • OTC meds (ephedrine/pseudoephedrine, caffeine, salicylates)

  • Illicit drugs


21
New cards

anxiety treatment

__ treatment

  • SSRIs or SNRIs

  • Buspirone

  • Hydroxyzine for insomnia

  • Gabapentin

  • CBT


22
New cards

monthly

Initial follow up interval for GAD treatment

23
New cards

anxiety diagnostics

__ diagnostics

  • BMP

  • ECG

  • Thyroid function

rule out metabolic causes


24
New cards

Buspirone

A serotonin 1A1\text{A} (5-HT1A)(5\text{-HT}_{1\text{A}}) receptor partial agonist approved as a non-benzodiazepine anxiolytic for the treatment of generalized anxiety disorder, having no potential for abuse or physical dependence.

25
New cards

Alpha-2-Delta (\alpha_2\delta) Ligands

Anticonvulsant compounds such as gabapentin and pregabalin that bind open voltage-sensitive calcium channels in the amygdala and corticostriatal-thalamocortical (CSTC) circuits, attenuating excitatory neurotransmitter release to reduce anxiety, fear, and worry.

26
New cards

Panic Disorder

An anxiety condition marked by recurrent, unexpected panic attacks alongside persistent anticipatory anxiety about future attacks or their consequences, commonly leading to maladaptive phobic avoidance behaviors.

27
New cards

Post-Traumatic Stress Disorder (PTSD)

A trauma- and stressor-related condition persisting for over 1 month1\text{ month} following exposure to severe psychological trauma, characterized by intrusive memories/flashbacks, persistent avoidance of trauma cues, negative alterations in mood/cognition, and alterations in arousal and reactivity.

28
New cards

Clinician-Administered PTSD Scale (CAPS)

A 30-item30\text{-item} structured clinical diagnostic interview considered the gold standard assessment tool for post-traumatic stress disorder, evaluating symptom onset, duration, distress, functional impairment, and interval change.

29
New cards

Prazosin

A centrally active alpha-11 adrenergic receptor antagonist frequently prescribed off-label in PTSD management to specifically alleviate trauma-related nightmares and nocturnal hyperarousal.

30
New cards

SBIRT

A comprehensive, evidence-based public health approach standing for Screening, Brief Intervention, and Referral to Treatment, designed to deliver early intervention for individuals with or at risk for substance use disorders.

31
New cards

CAGE Questionnaire

A 4-item4\text{-item} screening questionnaire for identifying alcohol use disorder over the past 12 months12\text{ months}, assessing whether the patient has felt the need to Cut down, felt Annoyed by criticism, felt Guilty, or used an Eye-opener drink in the morning.

32
New cards

Disulfiram

An aversive conditioning medication for chronic alcohol use disorder that irreversibly inhibits aldehyde dehydrogenase, causing an accumulation of acetaldehyde that produces nausea, vomiting, facial flushing, and hypotension if ethanol is ingested.

33
New cards

Acamprosate

A maintenance medication for alcohol dependence that modulates neurochemical balance by inhibiting excitatory glutamate neurotransmission and enhancing inhibitory gamma-aminobutyric acid (GABA\text{GABA}) neurotransmission.

34
New cards

Naltrexone

A competitive μ-opioid\mu\text{-opioid} receptor antagonist that attenuates the intoxicating reward properties of alcohol and opioids; available in oral formulation (Revia) and a long-acting monthly intramuscular injection (Vivitrol), requiring an opioid-free interval of at least 7 days7\text{ days} before initiation.

35
New cards

Naloxone

A rapid-acting, synthetic opioid receptor antagonist administered parenterally or intranasally to quickly reverse life-threatening respiratory depression and coma induced by opioid overdose.

36
New cards

Buprenorphine

A high-affinity partial μ-opioid\mu\text{-opioid} receptor agonist that prevents exogenous opioids from binding, effectively relieving opioid withdrawal symptoms and craving without producing substantial euphoria.

37
New cards

Clonidine

A centrally acting alpha-22 adrenergic agonist used in acute opioid detoxification to suppress autonomic hyperactivity symptoms (diarrhea, abdominal cramps, diaphoresis, tachycardia) without modifying subjective opioid cravings.

38
New cards

Chronic Insomnia Disorder

According to the ICSD-3-TR3\text{-TR}, a sleep disorder defined as difficulty initiating sleep, maintaining sleep, or waking earlier than desired (with latency/awakenings >30 minutes> 30\text{ minutes}) occurring at least 3 times per week3\text{ times per week} for at least 3 months3\text{ months}, causing daytime impairment despite adequate sleep opportunity.

39
New cards

Spielman 3P Model of Insomnia

A behavioral model of chronic insomnia conceptualized by three components: Predisposing factors (baseline traits increasing vulnerability), Precipitating events (acute stressors that trigger sleep disruption), and Perpetuating factors (compensatory behaviors and cognitive habits sustaining poor sleep over time).

40
New cards

Dual Orexin Receptor Antagonists (DORAs)

A class of insomnia medications including daridorexant, lemborexant, and suvorexant that selectively block hypocretin/orexin receptors to suppress wakefulness signals, suitable for sleep-onset and sleep-maintenance insomnia.

41
New cards

Adult ADHD DSM-5 Diagnostic Threshold

The requirement that adults manifest at least 55 persistent symptoms in the inattention category, the hyperactivity/impulsivity category, or both for at least 6 months6\text{ months}, with evidence that several symptoms were present before age 12 years12\text{ years} across multiple settings.

42
New cards

Adult ADHD Self-Report Scale (ASRS-v1.1)

An 18-item18\text{-item} standardized symptom checklist derived from DSM-IV/DSM-55 criteria used to screen for and assess the frequency of adult ADHD symptoms over the preceding 6 months6\text{ months}.